Ohio Gastroenterology Society Annual Meeting 2025

1. Overview
The Ohio Gastroenterology Society Annual Meeting 2025 provides a comprehensive update on the latest clinical practices, therapeutic strategies, and technological innovations in gastroenterology. The program covers a diverse array of crucial topics, including the comprehensive management of eosinophilic esophagitis, advances in endoscopic resection, perioperative protocols for patients on GLP-1 agonists, practical artificial intelligence applications in the GI clinic, and current therapeutic debates in inflammatory bowel disease (IBD).
Course Date: 2025
2. Learning Objectives

Evaluate and implement dietary therapies and long-term management strategies for patients with eosinophilic esophagitis (EoE) across their lifespan.

Apply innovative endoscopic surgical techniques and principles of advanced resection for managing complex lesions in the gastrointestinal tract.

Navigate the pharmacological considerations and perioperative management of gastroparesis in patients utilizing GLP-1 agonists.

Integrate practical artificial intelligence (AI) tools into the GI clinic to streamline patient care, documentation, and workflow efficiency.

Assess the clinical evidence and timing strategies regarding the early versus late use of anti-TNFα therapy in adult patients with Crohn’s disease.

3. Target Audience

Best for gastroenterologists and GI surgeons who want updates on endoscopic resection, GLP-1 pharmacology, AI integration, and IBD management.

4. Topics

01 Targeting a Brighter Future for Patients with Eosinophilic Esophagitis Across the Lifespan

02 Practical Tips to Diet Therapy in Eosinophilic Esophagitis

03 EoE Session Q&A

04 The Alphabet Soup of Endoscopic Resection

05 Endo-Surgery Innovation – Approach to Management of Lesions in the GI Tract

06 Endoscopic Resection Session Q&A

07 Pharmacology of GLP-1 Agonists and Gastroparesis – Perioperative Management

08 GLP-1 Sesion Q&A

09 Liver Transplant Update

10 Practical AI for the GI Clinic – Streamlining Care and Improving Efficiency

11 AI Session Q&A

12 Debate – Early vs Late Use of Anti-TNFα Therapy in Adult Patients With Crohn’s Disease

13 IBD Session Q&A